ALISE DOZIER: Open Payments
NPI 1053744516 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 32 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $211 · 2025 $612
Food & beverage: $555Education: $57
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 15 | $277 |
| Novartis Pharmaceuticals Corporation | 4 | $110 |
| OPKO Pharmaceuticals, LLC | 3 | $57 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Ardelyx, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $11 |
Products named: VELPHORO, RAYALDEE, Vanrafia, Fabhalta, FUROSCIX, FARXIGA, TAVNEOS, IBSRELA.
Industry payments across LA — which companies pay providers there.
